Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gajdos

Showing results (121-130 of 170) with videos related to

Pageof 17
Sort By:
British Journal of Clinical Pharmacology|December 23, 1998
Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserveD Annane, E Bellissant, V Sebille, et al.
Revue Neurologique|January 1, 1986
[The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases]J C Raphael, C Masson, V Morice, et al.
Critical Care Medicine|May 1, 1994
Effects of mechanical ventilation with normobaric oxygen therapy on the rate of air removal from cerebral arteriesD Annane, G Troché, F Delisle, et al.
Revue Neurologique|March 10, 2001
[Electrophysiologic study of 10 cases of Miller Fisher syndrome]M C Durand, C Goulon-Goéau, A Schweitzer, et al.
Neurology|November 14, 2001
Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodiesM Giraud, G Beaurain, A M Yamamoto, et al.
Pediatric Hematology and Oncology|April 1, 1999
Treatment of Hodgkin's disease in children with VAMP (vinblastine, adriamycin, methotrexate, prednisone) and VEPA (vinblastine, etoposide, prednisone, adriamycin)P Kavan, E Kabickova, J Koutecky, et al.
Journal of Neuroimmunology|September 1, 1993
Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravisM L Vieira, S Caillat-Zucman, P Gajdos, et al.
Casopis Lekaru Ceskych|February 24, 2001
[High-dose chemotherapy in the treatment of children with malignant lymphoma]E Kabícková, P Kavan, J Koutecký, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1991
Pharmacokinetic studies of ambenonium chloride in patients with myasthenia gravisC Tharasse-Bloch, C Chabenat, P Boucly, et al.
Journal of Neuroimmunology|August 1, 1994
Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravisA Cardona, H J Garchon, B Vernet-der-Garabedian, et al.
Pageof 17

Showing results (121-130 of 170) with videos related to

Sort By:
Pageof 17
British Journal of Clinical Pharmacology|December 23, 1998
Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserveD Annane, E Bellissant, V Sebille, et al.
Revue Neurologique|January 1, 1986
[The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases]J C Raphael, C Masson, V Morice, et al.
Critical Care Medicine|May 1, 1994
Effects of mechanical ventilation with normobaric oxygen therapy on the rate of air removal from cerebral arteriesD Annane, G Troché, F Delisle, et al.
Revue Neurologique|March 10, 2001
[Electrophysiologic study of 10 cases of Miller Fisher syndrome]M C Durand, C Goulon-Goéau, A Schweitzer, et al.
Neurology|November 14, 2001
Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodiesM Giraud, G Beaurain, A M Yamamoto, et al.
Pediatric Hematology and Oncology|April 1, 1999
Treatment of Hodgkin's disease in children with VAMP (vinblastine, adriamycin, methotrexate, prednisone) and VEPA (vinblastine, etoposide, prednisone, adriamycin)P Kavan, E Kabickova, J Koutecky, et al.
Journal of Neuroimmunology|September 1, 1993
Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravisM L Vieira, S Caillat-Zucman, P Gajdos, et al.
Casopis Lekaru Ceskych|February 24, 2001
[High-dose chemotherapy in the treatment of children with malignant lymphoma]E Kabícková, P Kavan, J Koutecký, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1991
Pharmacokinetic studies of ambenonium chloride in patients with myasthenia gravisC Tharasse-Bloch, C Chabenat, P Boucly, et al.
Journal of Neuroimmunology|August 1, 1994
Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravisA Cardona, H J Garchon, B Vernet-der-Garabedian, et al.
Pageof 17